Chargement en cours...
Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
BACKGROUND: Sodium-glucose cotransporter-2 (SGLT2) inhibitors (SGLT2i) showed benefits in type 1 diabetes mellitus (T1DM), but the risk of diabetic ketoacidosis (DKA) limits their use. Ability to predict DKA risk and therapeutic responses would enable appropriate patient selection for SGLT2i. We con...
Enregistré dans:
| Publié dans: | PLoS Med |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7771708/ https://ncbi.nlm.nih.gov/pubmed/33373368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1003461 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|